Little Green Pharma (ASX:LGP) Cash-to-Debt : 0.51 (As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Little Green Pharma Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Little Green Pharma's cash to debt ratio for the quarter that ended in Mar. 2025 was 0.51.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Little Green Pharma couldn't pay off its debt using the cash in hand for the quarter that ended in Mar. 2025.

The historical rank and industry rank for Little Green Pharma's Cash-to-Debt or its related term are showing as below:

ASX:LGP' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.51 Med: 1.79 Max: No Debt
Current: 0.51

During the past 6 years, Little Green Pharma's highest Cash to Debt Ratio was No Debt. The lowest was 0.51. And the median was 1.79.

ASX:LGP's Cash-to-Debt is ranked worse than
60.69% of 992 companies
in the Drug Manufacturers industry
Industry Median: 1.01 vs ASX:LGP: 0.51

Little Green Pharma Cash-to-Debt Historical Data

The historical data trend for Little Green Pharma's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Little Green Pharma Cash-to-Debt Chart

Little Green Pharma Annual Data

Trend

Jun19

Jun20

Jun21

Mar23

Mar24

Mar25

Cash-to-Debt

Get a 7-Day Free Trial

2.54

28.34

1.05

0.97

0.51

Little Green Pharma Semi-Annual Data
	Jun19	Jun20	Dec20	Jun21	Dec21	Mar23	Sep23	Mar24	Sep24	Mar25
Cash-to-Debt	Get a 7-Day Free Trial					1.05	1.07	0.97	1.00	0.51

Competitive Comparison of Little Green Pharma's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Little Green Pharma's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Little Green Pharma's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Little Green Pharma's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Little Green Pharma's Cash-to-Debt falls into.

Save Embed

;

Save Embed

;

Little Green Pharma Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Little Green Pharma's Cash to Debt Ratio for the fiscal year that ended in Mar. 2025 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	2.376	/	(2.482	+	2.187)
	=	0.51

Little Green Pharma's Cash to Debt Ratio for the quarter that ended in Mar. 2025 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	2.376	/	(2.482	+	2.187)
	=	0.51

Little Green Pharma (ASX:LGP) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Little Green Pharma Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Little Green Pharma's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Little Green Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Little Green Pharma Ltd (ASX:LGP) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

66 Kings Park Road, Level 2, Suite 2, West Perth, Perth, WA, AUS, 6005

Website

https://www.littlegreenpharma.com

Little Green Pharma Ltd is engaged in the vertically integrated medicinal cannabis business. The business activities of the company include cultivation, production, research and development, manufacturing, and distribution of medicinal cannabis products. The company's two key types of products available at Little Green Pharma are oils (which are ingested) and flowers (which are usually inhaled through vaporizing). It offers LGP-branded medicinal cannabis oil products in the Australian and European markets.

Little Green Pharma Headlines

No Headlines